Source:http://linkedlifedata.com/resource/pubmed/id/11596835
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
2001-10-12
|
| pubmed:abstractText |
To assess the cost effectiveness of a multidrug prepackaged regimen for Helicobacter pylori, the Hp-PAC (lansoprazole 30mg, clarithromycin 500 mg, amoxicillin 1 g, all twice daily), relative to alternative pharmacological strategies in the management of confirmed duodenal ulcer over a 1-year period from 2 perspectives: (i) a strict healthcare payer perspective (Ontario Ministry of Health) excluding the patient copayment; and (ii) a healthcare payer perspective including the patient copayment.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
T
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1170-7690
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
19
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
831-43
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11596835-Anti-Bacterial Agents,
pubmed-meshheading:11596835-Anti-Ulcer Agents,
pubmed-meshheading:11596835-Canada,
pubmed-meshheading:11596835-Cost-Benefit Analysis,
pubmed-meshheading:11596835-Decision Support Techniques,
pubmed-meshheading:11596835-Drug Therapy, Combination,
pubmed-meshheading:11596835-Economics, Pharmaceutical,
pubmed-meshheading:11596835-Helicobacter Infections,
pubmed-meshheading:11596835-Helicobacter pylori,
pubmed-meshheading:11596835-Humans,
pubmed-meshheading:11596835-Peptic Ulcer
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication.
|
| pubmed:affiliation |
Centre for Evaluation of Medicines, St Joseph's Hospital, Hamilton, Ontario, Canada.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|